We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molly Campbell

Science Writer

@mollyrcampbell

Latest Content From Molly Campbell

Scientists Left Perplexed at Latest Alzheimer’s Drug Data
Article

In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.

VIEW

Secrets of Herbal Antidepressant Synthesis Are Uncovered
News

A new collaboration by scientists from German and Canadian research institutes has shed light on the genes involved in the biosynthesis of hypericin.

VIEW

Ribosome-based Treatments: A Sought After Therapy Option for Orphan Diseases?
News

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

VIEW

Exploring the Potential of Protein Degradation-focused Drug Discovery
Blog

Ubiquigent's Jason Brown and Jason Mundin discuss the role of the ubiquitin cascade in cellular signaling and explain how it can be exploited to support protein degradation-focused drug discovery.

VIEW

Harnessing Gamma T Cells To Bring Effective Therapies to Patients
Blog

Technology Networks recently spoke with Natalie Mount, CEO of Adaptate BioTherapeutics, to learn more about the company's aims and the challenges faced when developing immunotherapies and advancing them into clinical studies.

VIEW

Sequencing the Microbiome
Infographic

Download this infographic to discover what the microbiome is, why it's important and how we can learn more from harnessing the power of sequencing.

VIEW

Plant Power: UK Scientists Are Hunting for the Medicines on Our Doorstep
News

A team of researchers from the Earlham Institute are exploring the genetics of UK wildflowers to discover medicines that, quite literally, may be on our doorstep.

VIEW

Thermo Fisher Scientific Joins the Pistoia Alliance
Blog

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.

VIEW

Fungi: An “Under Explored Resource” in Drug Discovery
News

In a new study published in Scientific Reports, scientists have combined embryology, mycology and chemistry to test secondary metabolites from >10,000 species of fungi for biological activity.

VIEW

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive
News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

VIEW